Citations (95)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Wojciech Kuban & Władysława Anna Daniel. (2021) Cytochrome P450 expression and regulation in the brain. Drug Metabolism Reviews 53:1, pages 1-29.
Read now
Read now
Cynthia Navarro-Mabarak, Rafael Camacho-Carranza & Jesús Javier Espinosa-Aguirre. (2018) Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases. Drug Metabolism Reviews 50:2, pages 95-108.
Read now
Read now
Francesca Toselli, Peter R. Dodd & Elizabeth M. J. Gillam. (2016) Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugs. Drug Metabolism Reviews 48:3, pages 379-404.
Read now
Read now
C. Woodland, T. T. Huang, E. Gryz, R. Bendayan & J. P. Fawcett. (2008) Expression, Activity and Regulation of CYP3A in Human and Rodent Brain. Drug Metabolism Reviews 40:1, pages 149-168.
Read now
Read now
Dal
Woong Choi, Brigitte Leininger-Muller, Maria Wellman, Young
Hwan Kim & Gerard Siest. (2004) CYTOCHROME P-450-MEDIATED DIFFERENTIAL OXIDATIVE MODIFICATION OF PROTEINS: ALBUMIN, APOLIPOPROTEIN E, AND CYP2E1 AS TARGETS. Journal of Toxicology and Environmental Health, Part A 67:23-24, pages 2061-2071.
Read now
Read now
Sharon Miksys & Rachel F. Tyndale. (2004) The Unique Regulation of Brain Cytochrome P450 2 (CYP2) Family Enzymes by Drugs and Genetics. Drug Metabolism Reviews 36:2, pages 313-333.
Read now
Read now
G. SMITH, M. J. STUBBINS, L. W. HARRIES & C. R. WOLF. (1998) Molecular genetics of the human cytochrome P450 monooxygenase superfamily. Xenobiotica 28:12, pages 1129-1165.
Read now
Read now
Alvaro Puga, Daniel W. Nebert, Ross A. McKinnon & Anil G. Menon. (1997) Genetic Polymorphisms in Human Drug-Metabolizing Enzymes: Potential Uses of Reverse Genetics to Identify Genes of Toxicological Relevance. Critical Reviews in Toxicology 27:2, pages 199-222.
Read now
Read now
Henry W. Strobel, Jun Geng, Hidenori Kawashima & Huamin Wang. (1997) Cytochrome P450-Dependent Biotransformation of Drugs and Other Xenobiotic Substrates in Neural Tissue. Drug Metabolism Reviews 29:4, pages 1079-1105.
Read now
Read now
Vijayalakshmi Ravindranath & Michael R. Boyd. (1995) Xenobiotic Metabolism in Brain. Drug Metabolism Reviews 27:3, pages 419-448.
Read now
Read now
Articles from other publishers (85)
Saima Jalil Imran, Barbora Vagaska, Jan Kriska, Miroslava Anderova, Mario Bortolozzi, Gino Gerosa, Patrizia Ferretti & Radim Vrzal. (2022) Aryl Hydrocarbon Receptor (AhR)-Mediated Signaling in iPSC-Derived Human Motor Neurons. Pharmaceuticals 15:7, pages 828.
Crossref
Crossref
Marlaina R. Stocco & Rachel F. Tyndale. 2022. Pharmacology and Toxicology of Cytochrome P450 – 60th Anniversary. Pharmacology and Toxicology of Cytochrome P450 – 60th Anniversary
73
106
.
Jeremie Gautheron, Christophe Morisseau, Wendy K Chung, Jamila Zammouri, Martine Auclair, Genevieve Baujat, Emilie Capel, Celia Moulin, Yuxin Wang, Jun Yang, Bruce D Hammock, Barbara Cerame, Franck Phan, Bruno Fève, Corinne Vigouroux, Fabrizio Andreelli & Isabelle Jeru. (2021) EPHX1 mutations cause a lipoatrophic diabetes syndrome due to impaired epoxide hydrolysis and increased cellular senescence. eLife 10.
Crossref
Crossref
Daniela Fanni, Federica Pinna, Clara Gerosa, Pasquale Paribello, Bernardo Carpiniello, Gavino Faa & Mirko Manchia. (2021)
Anatomical distribution and expression of
CYP
in humans: Neuropharmacological implications
. Drug Development Research 82:5, pages 628-667.
Crossref
Crossref
Megha Gautam & Ganesh Thapa. (2020) Cytochrome P450-mediated estrogen catabolism therapeutic avenues in epilepsy. Acta Neurologica Belgica 121:3, pages 603-612.
Crossref
Crossref
Jin Yu, Hong Zhu, Mark S. Kindy & Saeid Taheri. (2021) Cytochrome P450 CYP2E1 Suppression Ameliorates Cerebral Ischemia Reperfusion Injury. Antioxidants 10:1, pages 52.
Crossref
Crossref
Morteza Sarparast, Devon Dattmore, Jamie Alan & Kin Sing Stephen Lee. (2020) Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration. Nutrients 12:11, pages 3523.
Crossref
Crossref
Vasiliy A. Devyatkin, Olga E. Redina, Nataliya G. Kolosova & Natalia A. Muraleva. (2020) Single-Nucleotide Polymorphisms Associated with the Senescence-Accelerated Phenotype of OXYS Rats: A Focus on Alzheimer’s Disease-Like and Age-Related-Macular-Degeneration-Like Pathologies. Journal of Alzheimer's Disease 73:3, pages 1167-1183.
Crossref
Crossref
Geir Bjørklund, Lyudmila Pivina, Maryam Dadar, Yuliya Semenova, Md Mostafizur Rahman, Salvatore Chirumbolo & Jan Aaseth. (2020) Depleted uranium and Gulf War Illness: Updates and comments on possible mechanisms behind the syndrome. Environmental Research 181, pages 108927.
Crossref
Crossref
Xinyi Li, Dongzhen Yu, Huiqun Jie, Huiqun Zhou, Haibo Ye, Guo Ma, Lili Wan, Chunyan Li, Haibo Shi & Shankai Yin. (2019) Cytochrome P450 1A2 Is Incapable of Oxidizing Bilirubin Under Physiological Conditions. Frontiers in Pharmacology 10.
Crossref
Crossref
S-Y.A. Tsai, Raphael M. Bendriem & Chun-Ting D. Lee. (2019) The cellular basis of fetal endoplasmic reticulum stress and oxidative stress in drug-induced neurodevelopmental deficits. Neurobiology of Stress 10, pages 100145.
Crossref
Crossref
Lucio G. Costa. 2019. Biomarkers in Toxicology. Biomarkers in Toxicology
173
185
.
W. SlikkerJr.Jr. & C. Wang. 2018. Comprehensive Toxicology. Comprehensive Toxicology
24
40
.
Mirjam J. Eberhardt, Florian Schillers, Esther M. Eberhardt, Linus Risser, Jeanne de la Roche, Christine Herzog, Frank Echtermeyer & Andreas Leffler. (2017) Reactive metabolites of acetaminophen activate and sensitize the capsaicin receptor TRPV1. Scientific Reports 7:1.
Crossref
Crossref
W. A. García-Suástegui, L. A. Ramos-Chávez, M. Rubio-Osornio, M. Calvillo-Velasco, J. A. Atzin-Méndez, J. Guevara & D. Silva-Adaya. (2017) The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain. Oxidative Medicine and Cellular Longevity 2017, pages 1-14.
Crossref
Crossref
Aramandla Ramesh, Kenneth J. Harris & Anthony E. Archibong. 2017. Reproductive and Developmental Toxicology. Reproductive and Developmental Toxicology
745
763
.
Radka Václavíková, David J. Hughes & Pavel Souček. (2015) Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human disease. Gene 571:1, pages 1-8.
Crossref
Crossref
W. SlikkerJr.Jr. & C. Wang. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Lucio G. Costa & Claudia Pellacani. 2014. Biomarkers in Toxicology. Biomarkers in Toxicology
157
168
.
Jessica L. Barrington-Trimis, Susan Searles Nielsen, Susan Preston-Martin, W. James Gauderman, Elizabeth A. Holly, Federico M. Farin, Beth A. Mueller & Roberta McKean-Cowdin. (2013) Parental Smoking and Risk of Childhood Brain Tumors by Functional Polymorphisms in Polycyclic Aromatic Hydrocarbon Metabolism Genes. PLoS ONE 8:11, pages e79110.
Crossref
Crossref
Annmarie Ramkissoon, Aaron M. Shapiro, Margaret M. Loniewska & Peter G. Wells. 2013. Molecular Basis of Oxidative Stress. Molecular Basis of Oxidative Stress
237
310
.
Iris M. Booth Depaz, Francesca Toselli, Peter A. Wilce & Elizabeth M. J. Gillam. (2013) Differential Expression of Human Cytochrome P450 Enzymes from the CYP3A Subfamily in the Brains of Alcoholic Subjects and Drug-Free Controls. Drug Metabolism and Disposition 41:6, pages 1187-1194.
Crossref
Crossref
J C Stingl, J Brockmöller & R Viviani. (2012) Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function. Molecular Psychiatry 18:3, pages 273-287.
Crossref
Crossref
Aparajita Dey. 2013. Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism. Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism
1
104
.
N Amin, E Byrne, J Johnson, G Chenevix-Trench, S Walter, I M Nolte, J M Vink, R Rawal, M Mangino, A Teumer, J C Keers, G Verwoert, S Baumeister, R Biffar, A Petersmann, N Dahmen, A Doering, A Isaacs, L Broer, N R Wray, G W Montgomery, D Levy, B M Psaty, V Gudnason, A Chakravarti, P Sulem, D F Gudbjartsson, L A Kiemeney, U Thorsteinsdottir, K Stefansson, F J A van Rooij, Y S Aulchenko, J J Hottenga, F R Rivadeneira, A Hofman, A G Uitterlinden, C J Hammond, S-Y Shin, A Ikram, J C M Witteman, A C J W Janssens, H Snieder, H Tiemeier, B H R Wolfenbuttel, B A Oostra, A C Heath, E Wichmann, T D Spector, H J Grabe, D I Boomsma, N G Martin & C M van Duijn. (2011) Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM. Molecular Psychiatry 17:11, pages 1116-1129.
Crossref
Crossref
Vidya Perera, Annette S Gross, Hongmei Xu & Andrew J McLachlan. (2011) Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics. Journal of Pharmacy and Pharmacology 63:9, pages 1161-1168.
Crossref
Crossref
Aramandla Ramesh & Anthony E. Archibong. 2011. Reproductive and Developmental Toxicology. Reproductive and Developmental Toxicology
577
591
.
Stefania Vinci, Federico Ibba, Rosanna Longoni, Liliana Spina, Saturnino Spiga & Elio Acquas. (2010) Acetaldehyde elicits ERK phosphorylation in the rat nucleus accumbens and extended amygdala. Synapse 64:12, pages 916-927.
Crossref
Crossref
Simone L. Popp, Ina S. Abele, Miriam B. Buck, Matthias B. Stope, Leen J. Blok, Payman Hanifi-Moghaddam, Curt W. Burger, Peter Fritz & Cornelius Knabbe. (2010) Microsomal epoxide hydrolase expression in the endometrial uterine corpus is regulated by progesterone during the menstrual cycle. Journal of Molecular Histology 41:2-3, pages 111-119.
Crossref
Crossref
W. Slikker. 2010. Comprehensive Toxicology. Comprehensive Toxicology
277
288
.
Eun-Joo Shin, Guoying Bing, Jong Seok Chae, Tae Woo Kim, Jae-Hyung Bach, Dae Hun Park, Kiyofumi Yamada, Toshitaka Nabeshima & Hyoung-Chun Kim. (2009) Role of microsomal epoxide hydrolase in methamphetamine-induced drug dependence in mice. Journal of Neuroscience Research 87:16, pages 3679-3686.
Crossref
Crossref
Annalisa Nannelli, Francesco Rossignolo, Roberto Tolando, Paolo Rossato, Vincenzo Longo & P. Giovanni Gervasi. (2009) Effect of β-naphthoflavone on AhR-regulated genes (CYP1A1, 1A2, 1B1, 2S1, Nrf2, and GST) and antioxidant enzymes in various brain regions of pig. Toxicology 265:3, pages 69-79.
Crossref
Crossref
A. Marowsky, J. Burgener, J.R. Falck, J.-M. Fritschy & M. Arand. (2009) Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism. Neuroscience 163:2, pages 646-661.
Crossref
Crossref
Stefanie D. Krämer & Bernard Testa. (2009) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 6:10, pages 1477-1660.
Crossref
Crossref
C. Viaggi, F. Vaglini, C. Pardini, A. Caramelli & G.U. Corsini. (2009) MPTP-induced model of Parkinson's disease in cytochrome P450 2E1knockout mice. Neuropharmacology 56:8, pages 1075-1081.
Crossref
Crossref
H. Niazi Shahabi, L. Westberg, J. Melke, A. Håkansson, A. Carmine Belin, O. Sydow, L. Olson, B. Holmberg & H. Nissbrandt. (2009) Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson’s disease in a Swedish population. Journal of Neural Transmission 116:5, pages 567-573.
Crossref
Crossref
Mercè Correa, Cristina Viaggi, Miguel A. Escrig, María Pascual, Consuelo Guerri, Francesca Vaglini, Carlos M.G. Aragon & Giovanni U. Corsini. (2009) Ethanol intake and ethanol-induced locomotion and locomotor sensitization in Cyp2e1 knockout mice. Pharmacogenetics and Genomics 19:3, pages 217-225.
Crossref
Crossref
H. Niazi Shahabi, D.R. Andersson & H. Nissbrandt. (2008) Cytochrome P450 2E1 in the substantia nigra: Relevance for dopaminergic neurotransmission and free radical production. Synapse 62:5, pages 379-388.
Crossref
Crossref
Fabien Dutheil, Philippe Beaune & Marie-Anne Loriot. (2008) Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cytochrome P450 enzymes in normal and pathological human brain. Biochimie 90:3, pages 426-436.
Crossref
Crossref
Nidhi Kapoor, Aditya B. Pant, Alok Dhawan, Uppendra N. Dwievedi, Prahlad K. Seth & Devendra Parmar. (2007) Differences in the expression and inducibility of cytochrome P450 2B isoenzymes in cultured rat brain neuronal and glial cells. Molecular and Cellular Biochemistry 305:1-2, pages 199-207.
Crossref
Crossref
Marilyn C. Cornelis, Ahmed El-Sohemy & Hannia Campos. (2007) Microsomal epoxide hydrolase genotype and risk of myocardial infarction. Archives of Toxicology 81:9, pages 641-645.
Crossref
Crossref
Robert L. Haining & Mari Nichols-Haining. (2007) Cytochrome P450-catalyzed pathways in human brain: Metabolism meets pharmacology or old drugs with new mechanism of action?. Pharmacology & Therapeutics 113:3, pages 537-545.
Crossref
Crossref
Simonetta Gemma, Susanna Vichi & Emanuela Testai. (2007) Metabolic and genetic factors contributing to alcohol induced effects and fetal alcohol syndrome. Neuroscience & Biobehavioral Reviews 31:2, pages 221-229.
Crossref
Crossref
R. L. Haining. 2007. Handbook of Neurochemistry and Molecular Neurobiology. Handbook of Neurochemistry and Molecular Neurobiology
43
91
.
Zhengwen Jiang, Nadine Dragin, Lucia F. Jorge-Nebert, Martha V. Martin, F. Peter Guengerich, Eleni Aklillu, Magnus Ingelman-Sundberg, George J. Hammons, Beverly D. Lyn-Cook, Fred F. Kadlubar, Shannon N. Saldana, Michael Sorter, Alexander A. Vinks, Nassr Nassr, Oliver von Richter, Li Jin & Daniel W. Nebert. (2006) Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype. Pharmacogenetics and Genomics 16:5, pages 359-367.
Crossref
Crossref
Shigeyuki Uno, Timothy P. Dalton, Nadine Dragin, Christine P. Curran, Sandrine Derkenne, Marian L. Miller, Howard G. Shertzer, Frank J. Gonzalez & Daniel W. Nebert. (2006)
Oral Benzo[
a
]pyrene in
Cyp1
Knockout Mouse Lines: CYP1A1 Important in Detoxication, CYP1B1 Metabolism Required for Immune Damage Independent of Total-Body Burden and Clearance Rate
. Molecular Pharmacology 69:4, pages 1103-1114.
Crossref
Crossref
Mei Liu, Anyang Sun, Eun-Joo Shin, Xianxi Liu, Sang-Geon Kim, Cecil R. Runyons, William Markesbery, Hyoung-Chun Kim & Guoying Bing. (2006) Expression of microsomal epoxide hydrolase is elevated in Alzheimer's hippocampus and induced by exogenous β-amyloid and trimethyl-tin. European Journal of Neuroscience 23:8, pages 2027-2034.
Crossref
Crossref
Meenal Joshi & Rachel F. Tyndale. (2006) Regional and cellular distribution of CYP2E1 in monkey brain and its induction by chronic nicotine. Neuropharmacology 50:5, pages 568-575.
Crossref
Crossref
Yu. I. Borodin, I. V. Maiborodin, A. F. Safina & D. N. Strunkin. (2005) The Possibility of Cytochrome P450 1A1/1A2 Induction in Cells of Distant Lymph Nodes of Rats after Enteral Treatment with Benzo[a]pyrene. Bulletin of Experimental Biology and Medicine 140:5, pages 564-567.
Crossref
Crossref
Shankar J. Chinta, Reddy P. Kommaddi, Cheri M. Turman, Henry W. Strobel & Vijayalakshmi Ravindranath. (2005)
Constitutive expression and localization of cytochrome P‐450 1A1 in rat and human brain: presence of a splice variant form in human brain
1
. Journal of Neurochemistry 93:3, pages 724-736.
Crossref
Crossref
Marta J. Narvaez, Garret R. Anderson, George V. Pickwell & Linda C. Quattrochi. (2005)
Characterization of adjacent E‐box and nuclear factor 1‐like DNA binding sequence in the human
CYP1A2
promoter
. Journal of Biochemical and Molecular Toxicology 19:2, pages 78-86.
Crossref
Crossref
C. Malaplate-Armand, B. Leininger-Muller & A.-M. Batt. (2004) Les cytochromes P450 astrocytaires, une famille d’enzymes clés dans le métabolisme cérébral et la neuroprotection. Revue Neurologique 160:6-7, pages 651-658.
Crossref
Crossref
Gary Ginsberg, William SlikkerJrJr, James Bruckner & Babasaheb Sonawane. (2004) Incorporating children's toxicokinetics into a risk framework.. Environmental Health Perspectives 112:2, pages 272-283.
Crossref
Crossref
Guillermo Gervasini, Juan Antonio Carrillo & Julio Benitez. (2004) Potential Role of Cerebral Cytochrome P450 in Clinical Pharmacokinetics. Clinical Pharmacokinetics 43:11, pages 693-706.
Crossref
Crossref
Lisa A Howard, Sharon Miksys, Ewa Hoffmann, Deborah Mash & Rachel F Tyndale. (2003) Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics. British Journal of Pharmacology 138:7, pages 1376-1386.
Crossref
Crossref
M.L. Avery, C.E. Meek & K.L. Audus. (2003) The Presence of Inducible Cytochrome P450 Types 1A1 and 1A2 in the BeWo Cell Line. Placenta 24:1, pages 45-52.
Crossref
Crossref
Ahmad AhmadiPia Jönsson, Ulf Flodin & Peter Söderkvist. (2016) Interaction between smoking and glutathione S-transferase polymorphisms in solvent-induced chronic toxic encephalopathy. Toxicology and Industrial Health 18:6, pages 289-296.
Crossref
Crossref
Adriana M. Doi, Paula E. Patterson & Evan P. Gallagher. (2002) Variability in Aflatoxin B1–Macromolecular Binding and Relationship to Biotransformation Enzyme Expression in Human Prenatal and Adult Liver. Toxicology and Applied Pharmacology 181:1, pages 48-59.
Crossref
Crossref
Tracy A. Glauser. (2016) Advancing the Medical Management of Epilepsy: Disease Modification and Pharmacogenetics. Journal of Child Neurology 17:1_suppl, pages S85-S93.
Crossref
Crossref
G. U. Corsini, R. Maggio & F. Vaglini. 2002. Dopamine in the CNS II. Dopamine in the CNS II
321
386
.
Federico M. Farin, Patricia Janssen, Sean Quigley, Denise Abbott, Christopher Hassett, Terri Smith-Weller, Gary M. Franklin, Phillip D. Swanson, W. T. LongstrethJrJr, Curtis J. Omiecinski & Harvey Checkoway. (2001) Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's disease. Pharmacogenetics 11:8, pages 703-708.
Crossref
Crossref
Vural Özdemir, Werner Kalow, Paul Posner, Evan J. Collins, James L. Kennedy, Bing-Kou Tang, Lawrence J. Albers, Christopher Reist, Rochelle Roy, Winston Walkes & Pegah Afra. (2001) CYP1A2 Activity as Measured by a Caffeine Test Predicts Clozapine and Active Metabolite Norclozapine Steady-State Concentration in Patients With Schizophrenia. Journal of Clinical Psychopharmacology 21:4, pages 398-407.
Crossref
Crossref
Xing-Mei Han, Dong-Sheng Ou-Yang, Pei-Xin Lu, Chang-Hong Jiang, Yan Shu, Xiao-Ping Chen, Zhi-Rong Tan & Hong-Hao Zhou. (2001) Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2. Pharmacogenetics 11:5, pages 429-435.
Crossref
Crossref
Ning Liu, Qing-Yu Zhang, Dilip Vakharia, Deborah Dunbar & Laurence S. Kaminsky. (2001) Induction of CYP1A by Benzo[k]fluoranthene in Human Hepatocytes: CYP1A1 or CYP1A2?. Archives of Biochemistry and Biophysics 389:1, pages 130-134.
Crossref
Crossref
Anup Dey, John E Jones & Daniel W Nebert. (1999) Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization. Biochemical Pharmacology 58:3, pages 525-537.
Crossref
Crossref
Janet J. Diliberto, Deborah E. Burgin & Linda S. Birnbaum. (1999) Effects of CYP1A2 on Disposition of 2,3,7,8-Tetrachlorodibenzo-p-dioxin, 2,3,4,7,8-Pentachlorodibenzofuran, and 2,2′,4,4′,5,5′-Hexachlorobiphenyl in CYP1A2 Knockout and Parental (C57BL/6N and 129/Sv) Strains of Mice. Toxicology and Applied Pharmacology 159:1, pages 52-64.
Crossref
Crossref
Julie L. Hutson & Sunitha N. Wickramasinghe. (1999) Expression of CYP2E1 by human monocyte-derived macrophages. The Journal of Pathology 188:2, pages 197-200.
Crossref
Crossref
Margaret Warner & Jan-Åke Gustafsson. 1999. Neurosteroids. Neurosteroids
51
65
.
Bernd Ibach, Kurt Appel, Peter Gebicke-Haerter, Ralf Peter Meyer, Thomas Friedberg, Rolf Knoth & Benedikt Volk. (1998) Effect of phenytoin on cytochrome P450 2B mRNA expression in primary rat astrocyte cultures. Journal of Neuroscience Research 54:3, pages 402-411.
Crossref
Crossref
Devendra Parmar, Alok Dhawan, Monika Dayal & Prahlad K. Seth. (2016) Immunochemical and Biochemical Evidence for Expression of Phenobarbital-and 3-Methylcholanthrene-Inducible Isoenzymes of Cytochrome P450 in Rat Brain. International Journal of Toxicology 17:6, pages 619-630.
Crossref
Crossref
Dennis C. Morse, Adam P. Stein, Paul E. Thomas & Herbert E. Lowndes. (1998) Distribution and Induction of Cytochrome P450 1A1 and 1A2 in Rat Brain. Toxicology and Applied Pharmacology 152:1, pages 232-239.
Crossref
Crossref
C. R. Rieder, D. B. Ramsden & A. C. Williams. (1998) Cytochrome P450 1B1 mRNA in the human central nervous system. Molecular Pathology 51:3, pages 138-142.
Crossref
Crossref
P.M Watts, A.G Riedl, D.C Douek, R.J Edwards, A.R Boobis, P Jenner & C.D Marsden. (1998) Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase. Neuroscience 86:2, pages 511-519.
Crossref
Crossref
Christopher Hassett, Elizabeth M Laurenzana, Jaspreet S Sidhu & Curtis J Omiecinski. (1998) Effects of Chemical Inducers on Human Microsomal Epoxide Hydrolase in Primary Hepatocyte Cultures. Biochemical Pharmacology 55:7, pages 1059-1069.
Crossref
Crossref
MARK R. ANDERSEN, FEDERICO M. FARIN & CURTIS J. OMIECINSKI. (1998) Quantification of Multiple Human Cytochrome P450 mRNA Molecules Using Competitive Reverse Transcriptase-PCR. DNA and Cell Biology 17:3, pages 231-238.
Crossref
Crossref
E. Hedlund, J-Å. Gustafsson & M. Warner. (1998) Cytochrome P450 in the brain: 2B or not 2B. Trends in Pharmacological Sciences 19:3, pages 82-85.
Crossref
Crossref
ANDREA GAEDIGK, J. STEVEN LEEDER & DENIS M. GRANT. (1997) Tissue-Specific Expression and Alternative Splicing of Human Microsomal Epoxide Hydrolase. DNA and Cell Biology 16:11, pages 1257-1266.
Crossref
Crossref
H. Boutelet-Bochan, Y. Huang & M.R. Juchau. (1997) Expression ofCYP2E1during Embryogenesis and Fetogenesis in Human Cephalic Tissues: Implications for the Fetal Alcohol Syndrome. Biochemical and Biophysical Research Communications 238:2, pages 443-447.
Crossref
Crossref
Andrew G Riedl, Paul M Watts, Robert J Edwards, Alan R Boobis, Peter Jenner & C.David Marsden. (1996) Selective localisation of P450 enzymes and NADPH-P450 oxidoreductase in rat basal ganglia using anti-peptide antisera. Brain Research 743:1-2, pages 324-328.
Crossref
Crossref
F. Takakubo, M. Yamamoto, N. Ogawa, Y. Yamashita, Y. Mizuno & I. Kondo. (1996) Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease. Journal of Neural Transmission 103:7, pages 843-849.
Crossref
Crossref
W A SukG CollmanT Damstra. (1996) Human biomonitoring: research goals and needs.. Environmental Health Perspectives 104:suppl 3, pages 479-483.
Crossref
Crossref
J T HeinonenJ S SidhuM T ReillyF M FarinC J OmiecinskiD L EatonT J Kavanagh. (1996) Assessment of regional cytochrome P450 activities in rat liver slices using resorufin substrates and fluorescence confocal laser cytometry.. Environmental Health Perspectives 104:5, pages 536-543.
Crossref
Crossref
L G Costa. (1996) Biomarker research in neurotoxicology: the role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigations.. Environmental Health Perspectives 104:suppl 1, pages 55-67.
Crossref
Crossref
Terence A. Ketter, David A. Flockhart, Robert M. Post, Kirk Denicoff, Peggy J. Pazzaglia, Lauren B. Marangell, Mark S. George & Ann M. Callahan. (1995) The Emerging Role of Cytochrome P450 3A in Psychopharmacology. Journal of Clinical Psychopharmacology 15:6, pages 387-398.
Crossref
Crossref
F. Peter Guengerich. 1995. Cytochrome P450. Cytochrome P450
473
535
.